Theodoros Karampatakis, Katerina Tsergouli, Eleni Kandilioti, Anna Nikopoulou, Helen Katsifa, Melina Kachrimanidou
{"title":"Implication of COVID-19 pandemic on the incidence of <i>Clostridioides difficile</i> infection in a Greek tertiary hospital.","authors":"Theodoros Karampatakis, Katerina Tsergouli, Eleni Kandilioti, Anna Nikopoulou, Helen Katsifa, Melina Kachrimanidou","doi":"10.1099/jmm.0.001689","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> <i>C. difficile</i> infection (CDI) represents an important global threat. In the COVID-19 era, the multifactorial nature of CDI has emerged.<b>Hypothesis - Aim.</b> The aim was to assess the impact of COVID-19 pandemic on the incidence of CDI in a Greek hospital.<b>Methodology.</b> A retrospective study was performed throughout a 51 month period (January 2018 to March 2022), divided into two periods: pre-pandemic (January 2018 to February 2020) and COVID-19 pandemic (March 2020 to March 2022). The effects of the pandemic compared to the pre-pandemic period on the incidence of CDI [expressed as infections per 10 000 bed days (IBD)] were studied using interrupted time-series analysis.<b>Results.</b> Throughout the study, there was an increase in the monthly CDI incidence from 0.00 to 11.77 IBD (<i>P</i><0.001). Interrupted time-series disclosed an increase in CDI incidence during the pre-pandemic period from 0.00 to 3.36 IBD (<i>P</i><0.001). During the COVID-19 pandemic period the linear trend for monthly CDI rose from 2.65 to 13.93 IBD (<i>P</i><0.001). The increase rate was higher during the COVID-19 pandemic period (r<sub>2</sub> = +0.47) compared to the pre-pandemic period (r<sub>1</sub> = +0.16).<b>Conclusion.</b> A significant increase of CDI incidence was observed, with the rate of the rise being more intense during the COVID-19 pandemic.</p>","PeriodicalId":16343,"journal":{"name":"Journal of medical microbiology","volume":"72 5","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical microbiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001689","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction.C. difficile infection (CDI) represents an important global threat. In the COVID-19 era, the multifactorial nature of CDI has emerged.Hypothesis - Aim. The aim was to assess the impact of COVID-19 pandemic on the incidence of CDI in a Greek hospital.Methodology. A retrospective study was performed throughout a 51 month period (January 2018 to March 2022), divided into two periods: pre-pandemic (January 2018 to February 2020) and COVID-19 pandemic (March 2020 to March 2022). The effects of the pandemic compared to the pre-pandemic period on the incidence of CDI [expressed as infections per 10 000 bed days (IBD)] were studied using interrupted time-series analysis.Results. Throughout the study, there was an increase in the monthly CDI incidence from 0.00 to 11.77 IBD (P<0.001). Interrupted time-series disclosed an increase in CDI incidence during the pre-pandemic period from 0.00 to 3.36 IBD (P<0.001). During the COVID-19 pandemic period the linear trend for monthly CDI rose from 2.65 to 13.93 IBD (P<0.001). The increase rate was higher during the COVID-19 pandemic period (r2 = +0.47) compared to the pre-pandemic period (r1 = +0.16).Conclusion. A significant increase of CDI incidence was observed, with the rate of the rise being more intense during the COVID-19 pandemic.
期刊介绍:
Journal of Medical Microbiology provides comprehensive coverage of medical, dental and veterinary microbiology, and infectious diseases. We welcome everything from laboratory research to clinical trials, including bacteriology, virology, mycology and parasitology. We publish articles under the following subject categories: Antimicrobial resistance; Clinical microbiology; Disease, diagnosis and diagnostics; Medical mycology; Molecular and microbial epidemiology; Microbiome and microbial ecology in health; One Health; Pathogenesis, virulence and host response; Prevention, therapy and therapeutics